Spotlight on the Cancer Cell: Intrinsic Properties and Vulnerabilities for Therapeutics (A3)
January 26-29, 2026
| Embassy Suites by Hilton Raleigh Durham Research Triangle, Cary, NC, United States
Anwesha Dey, Laura D. Attardi and Mariam Jamal-Hanjani
Scholarship Deadline: Nov. 3, 2025 | Abstract Deadline: Jan. 7, 2026 | Early Registration Deadline: Nov. 26, 2025
| 4:00–8:00 PM |
Registration |
|
| 6:00–8:00 PM |
Welcome Mixer |
|
Tuesday, January 27, 2026
| 8:00–8:30 AM |
Poster Setup |
|
| 8:15–5:00 PM |
Poster Viewing |
|
| 8:30–9:30 AM |
Welcome and Keynote Address |
|
| |
Kevan M. Shokat, University of California, San Francisco
Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras |
|
| 9:30–11:45 AM |
Cancer Evolution, Tumor Heterogeneity and Metastasis |
|
| |
Mariam Jamal-Hanjani, University College London
Tumor Evolution and Metastasis Revealed through Research Autopsies in PEACE |
|
| |
Manuel Valiente, Spanish National Cancer Research Centre
Metastatic Colonization and the Development of Brain Metastasis |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 10:00–10:20 AM |
Coffee Break |
|
| 12:30–2:30 PM |
Poster Session 1 |
|
| 2:30–4:30 PM |
Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Drugging Cancer Pathways and New Targets on the Horizon |
|
| |
Kevin Marks, Delphia Therapeutics
Exploiting Pathway Activation as a New Form of Synthetic Lethality |
|
| |
Gregory L. Verdine, Harvard University and FogPharma
Drugging Oncogenic Transcriptional Drivers |
|
| |
Anwesha Dey, Genentech, Inc.
Targeting the PI3K Pathway in Cancers |
|
| |
Peter C. Scacheri, Amgen Research
Targeting Signaling Pathway in Cancers |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
On Own for Dinner |
|
Wednesday, January 28, 2026
| 8:00–8:30 AM |
Poster Setup |
|
| 8:15–5:00 PM |
Poster Viewing |
|
| 8:30–11:30 AM |
Cancer Cell Vulnerabilities and Therapeutic Opportunities |
|
| |
Ashok R. Venkitaraman, Cancer Science Institute
p53 and Therapeutic Vulnerabilities |
|
| |
Karen M. Cichowski, Brigham and Women's Hospital, Harvard Medical School
Chemical Synthetic Lethal Interactions for the Development of Combinatorial Therapies |
|
| |
LaQuita Jones, Cincinnati Children's Hospital Medical Center
Unexpected Resistance Mechanisms Underlying AML Targeted Therapy |
|
| |
Josh Plotnik, AbbVie, Inc.
Novel Synthetic Lethal Targets in Cancer |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:30–9:50 AM |
Coffee Break |
|
| 12:30–2:30 PM |
Poster Session 2 |
|
| 3:00–4:30 PM |
Career Roundtable |
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Metabolic Rewiring in Cancer and Metabolic Approaches to Therapy |
|
| |
Ralph J. DeBerardinis, University of Texas Southwestern Medical Center
Cell-Intrinsic Metabolic Features Contributing to Cancer Initiation and Progression |
|
| |
Poul H Sorensen, University of British Columbia
Metabolic Adaptation Mechanisms that Confer Resistance to Oxidative Stress in Cancer Cells |
|
| |
Dohoon Kim, University of Massachusetts Medical School
Cancer Metabolism and Metabolic Toxicity |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
On Own for Dinner |
|
Thursday, January 29, 2026
| 8:30–11:30 AM |
Cellular Plasticity and Cell State Changes in Cancer |
|
| |
Karuna Ganesh, Memorial Sloan Kettering Cancer Center
Regenerative Plasticity during Colorectal Cancer Metastasis |
|
| |
Cédric Blanpain, Universite Libre de Bruxelles
Stem Cell Function in Development, Homeostasis and Cancer |
|
| |
Laura D. Attardi, Stanford University School of Medicine
p53 Governs Cell State Changes in Lung and Pancreatic Cancers |
|
| |
David Millan, Auron Therapeutics
Targeting Drivers of Tumor Cell Plasticity |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:30–9:50 AM |
Coffee Break |
|
| 11:00–2:30 PM |
On Own for Lunch |
|
| 2:30–4:30 PM |
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–6:45 PM |
Looking to the Future: Provocative New Themes in Cancer |
|
| |
Laura Wood, Johns Hopkins University School of Medicine
New Insights into Tumor Development from CODA 3D Reconstruction |
|
| |
Hoifung Poon, Microsoft Health Futures
Multimodal Generative AI for Precision Health |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 6:45–7:00 PM |
Meeting Wrap-Up: Outcomes and Future Directions |
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 PM |
Entertainment |
|
